featured
Clinical Outcomes of Subcutaneous vs Intravenous Infliximab Maintenance Therapy in Patients With IBD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Inflammatory Bowel Diseases
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
One-Year Clinical Outcomes of Subcutaneous Infliximab Maintenance Therapy Compared With Intravenous Infliximab Maintenance Therapy in Patients With Inflammatory Bowel Disease: A Prospective Cohort Study
Inflamm. Bowel Dis. 2024 Apr 03;30(4)517-528, SN Hong, J Hye Song, S Jin Kim, Y Ha Park, C Wan Choi, J Eun Kim, E Ran Kim, D Kyung Chang, YH KimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.